CytosinLab Therapeutics Co.
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $45M
Investors
- 8
About CytosinLab Therapeutics Co.
, Ltd. operates as a biomedical company that focuses on the research and development of new drugs for major diseases such as cancer. The company's founding team includes academicians from the Chinese Academy of Sciences, pharmaceutical companies. Several academic institutions, such as Shanghai Institute of Chinese Academy of Sciences, Fudan University, and Jiaotong University, have cooperated with the company. It has set up a R&D center in Shanghai and a branch office in Shenzhen. CytosinLab built a EpigenPlus platform that uses for targeting epigenetic therapeutic targets and epigenetic regulatory mechanisms, including tumor mismatch repair mechanisms, tumor differentiation mechanisms, and tumor metabolism mechanisms. The company has also developed innovative drugs CTS2190 and CTS2016, which can be used to treat hematological and solid tumors. Its PRMT5-MTA complex inhibitor will also be in clinical Phase I trials in 2024.
Who invested in CytosinLab Therapeutics Co.
8 investors across 3 rounds
See all investors in CytosinLab Therapeutics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CytosinLab Therapeutics Co.
Who invested in CytosinLab Therapeutics Co.?
CytosinLab Therapeutics Co. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CytosinLab Therapeutics Co. raised?
CytosinLab Therapeutics Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CytosinLab Therapeutics Co. last raise money?
CytosinLab Therapeutics Co.'s most recent round on record is a Series A, in Dec 2023.
What does CytosinLab Therapeutics Co. do?
CytosinLab Therapeutics Co. is a biotechnology company.
Where is CytosinLab Therapeutics Co. headquartered?
CytosinLab Therapeutics Co. is headquartered in Shanghai, China.
Which VCs invest in companies like CytosinLab Therapeutics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CytosinLab Therapeutics Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CytosinLab Therapeutics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.